![Vanessa Ragaglia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vanessa Ragaglia
Corporate Officer/Principal en Garnet BioTherapeutics, Inc. .
Cargos activos de Vanessa Ragaglia
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Garnet BioTherapeutics, Inc.
![]() Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 01/01/2000 | - |
Director Técnico/Científico/I+D | 01/01/2000 | - | |
Celebration Stem Cell Centre | Corporate Officer/Principal | - | - |
Historial de carrera de Vanessa Ragaglia
Formación de Vanessa Ragaglia.
Trinity College (Connecticut) | Undergraduate Degree |
The Ohio State University College of Medicine | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorial
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Garnet BioTherapeutics, Inc.
![]() Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Commercial Services |
Celebration Stem Cell Centre |
- Bolsa de valores
- Insiders
- Vanessa Ragaglia
- Experiencia